Dr. Zahra Sabahi is a Theranostics (neuroendocrine) Fellow at Royal North Shore Hospital, as well as a Research Fellow at Garvan Institute and St. Vincent’s Hospital Sydney.

She leads the Phase IIb imaging trial “BEST” focusing on metastatic hormone-positive breast cancer, utilizing a novel PET tracer.

Zahra completed her nuclear medicine advanced training in major Sydney teaching hospitals including St. Vincent’s, Liverpool, Bankstown, and Royal North Shore Hospital.

Her primary research focus lies in molecular imaging of breast cancer and its Theranostics implications.